Immunologic Research

, Volume 29, Issue 1, pp 41–53

Evolution of HLA antibody detection

Technology emulating biology
  • Robert A. Bray
  • Peter W. Nickerson
  • Ronald H. Kerman
  • Howard M. Gebel
Immunology at Emory University

DOI: 10.1385/IR:29:1-3:041

Cite this article as:
Bray, R.A., Nickerson, P.W., Kerman, R.H. et al. Immunol Res (2004) 29: 41. doi:10.1385/IR:29:1-3:041

Abstract

New technological advances in the field of histocompatibility have provided an approach to system atically address the specificity of positive lymphocyte crossmatches. These approaches can now confirm whether a positive crossmatch is (or is not) due to class I and/or class II antibodies directed against donor HLA antigens. The information gained from the application of these sensitive and specific technologies can be used to predict crossmatch results for highly sensitized patients. In summary, these emerging technologies have provided the tools to reliably determine the clinical relevance of a positive lymphocyte crossmatch.

Key words

Transplantation Crossmatch Flow cytometry Alloantibody HLA 

Copyright information

© Humana Press Inc 2004

Authors and Affiliations

  • Robert A. Bray
    • 1
  • Peter W. Nickerson
    • 2
  • Ronald H. Kerman
    • 3
  • Howard M. Gebel
    • 1
  1. 1.Department of PathologyEmory University HospitalAtlanta
  2. 2.Faculty of MedicineUniversity of ManitobaWinnipegCanada
  3. 3.Department of SurgeryThe University of Texas Medical SchoolHouston

Personalised recommendations